Researchers identify biological markers of treatment-resistant aggressive lymphoma
By
Goethe University FrankfurtJul 3 2026Reviewed
Summary
Researchers from Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified biological features that distinguish particularly aggressive forms of lymphoma, especially in high-risk patients who do not respond well to standard therapy. By combining genetic and proteomic analyses, they discovered tumor characteristics that could enable earlier identification of treatment-resistant cases. This could allow high-risk patients to receive alternative, more effective therapies from the outset rather than undergoing ineffective standard treatment. The findings are based on experimental laboratory research.
Source
bskyResearchers identify biological markers of treatment-resistant aggressive lymphomanews-medical.netKey quotes
· 3 pulledResearchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized.
By combining genetic and proteomic analyses, the scientists were able to identify biological characteristics of tumors, particularly in high-risk patients for whom standard therapy offers little chance of cure.
In the future, such patients could receive alternative, more effective therapies directly.
You might also wanna read
Pan-cancer AI atlas reveals diversity and spatial organization of tertiary lymphoid structures in tumors
Researchers built a pan-cancer atlas of tertiary lymphoid structures (TLSs) in human tumors, developing an AI-based framework to detect and
scim.ag·15d ago
A hidden weakness in deadly cancers could lead to powerful new treatments
A hidden weakness in deadly cancers could lead to powerful new treatments
Mayo Clinic study reveals immune cells begin preparing to fight cancer earlier than thought
Mayo Clinic researchers have discovered that some cancer-fighting immune cells (T cells) begin preparing to fight cancer much earlier than p
mayocl.in·10d ago
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
Breast Cancer Treatment Strategies: AI ± CDK4/6 Inhibitors, Biomarkers, and ESR1 Mutations
This article appears to be a medical education piece focused on breast cancer treatment strategies, specifically discussing patients progres
mdsc.pe·12d ago
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic
rockefeller.edu·9mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.